Back to search

University of Alabama Birmingham

Epigenetic Dysregulation in Levodopa-Induced Dyskinesia

Abstract

dc:description.abstract

Levodopa-induced dyskinesia (LID) is a persistent behavioral sensitization that develops after repeated levodopa (L-DOPA) exposure in Parkinson disease (PD) patients. LID is characterized by a “priming effect”, whereby initial administrations of L-DOPA trigger a sensitized biochemical and transcriptional response upon subsequent administrations of L-DOPA. In neurons, transcriptional regulation through dynamic changes to epigenetic modifications, including DNA methylation and histone acetylation, have been shown pivotal to many long-term behavioral modifications; however, their role in LID has been minimally explored. Using a rodent model, we show LID development leads to the aberrant expression of DNA demethylating enzymes and locus-specific changes to DNA methylation at the promoter regions of genes aberrantly transcribed following L-DOPA treatment. Looking for dynamic DNA methylation in LID genome-wide, we used reduced representation bisulfite sequencing and found an extensive reorganization of the dorsal striatal methylome. LID development led to significant demethylation at many important regulatory areas of aberrantly transcribed genes. We then used pharmacologic treatments that alter DNA methylation bi-directionally and found them sufficient to modulate dyskinetic behaviors. Although this early evidence indicates that alterations in epigenetic modifications are involved in the development of LID, the proteins necessary for the functional interpretation of these marks remains a mystery. To address this issue, we further show that dyskinesia development induces alterations in bromodomain and extraterminal motif (BET) protein expression, known readers of histone acetylation, leading to their enhanced occupation at the promoter and enhancer regions of genes aberrantly transcribed following dyskinesia development. When BET function is blocked using a pharmacologic inhibitor, JQ1, it was found sufficient to hinder LID development. We further assessed JQ1's effect on the striatal sensitization necessary to LID expression finding it capable of blocking the sensitized transcription of several immediate early genes by inhibiting the identified enhancements in BET protein binding. Together, these findings demonstrate that L-DOPA induces widespread changes to the striatal epigenome, and that aberrant regulation of these modifications is required for the transcriptional dysfunction and maintenance of LID.

Degree

thesis:*
Level thesis:degree_level
Dissertation

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Figge, David Anthony
Contributors dc:contributor
  • David G Standaert
  • David Sweatt
  • Erik Roberson
  • Lucas Pozzo-Miller
  • Haydeh Payami
  • Robin G Lorenz

Subjects

dc:subject × 7

Identifiers

dc:identifier.*

Chain of custody

source
Harvested from
University of Alabama Birmingham
Base URL
digitalcommons.library.uab.edu/do/oai/
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
citation

Figge, David Anthony. Epigenetic Dysregulation in Levodopa-Induced Dyskinesia. Dissertation thesis, https://digitalcommons.library.uab.edu/etd-collection/1645